Teriparatide Succinimide contains a succinimide intermediate formed through asparagine or aspartate cyclization within the teriparatide backbone. The constrained ring alters local geometry and hydrogen-bonding patterns. Researchers examine its formation under stress conditions to understand degradation pathways. Applications include peptide-stability research, impurity profiling, and conformational analysis.
CAT No: Z10-101-167
Teriparatide succinimide is a synthetic peptide derivative modeled after a biologically active fragment of human parathyroid hormone (PTH). As a chemically modified peptide, it retains key structural motifs critical for receptor interaction, while the succinimide moiety may confer distinct physicochemical properties relevant to research and development contexts. The compound is widely recognized for its relevance in bone biology, receptor signaling studies, and peptide engineering, offering a valuable tool for scientists investigating peptide-receptor dynamics, post-translational modifications, and structure-activity relationships within the parathyroid hormone family. Its synthetic accessibility and well-characterized sequence make it suitable for controlled experimental designs in both fundamental and applied biochemical research.
Receptor-binding assays: Teriparatide succinimide is frequently used in in vitro receptor-binding studies to elucidate the molecular interactions between PTH analogs and the parathyroid hormone 1 receptor (PTH1R). By incorporating the succinimide modification, researchers can investigate how structural alterations influence affinity, selectivity, and downstream signaling events. Such assays are instrumental in mapping ligand-receptor interfaces, quantifying binding kinetics, and supporting the rational design of novel peptide ligands with tailored pharmacological profiles.
Signal transduction research: The compound provides a robust platform for dissecting intracellular signaling cascades initiated by PTH receptor activation. In cellular models, it can be employed to stimulate cyclic AMP production, monitor calcium flux, or assess the activation of protein kinase pathways. These applications enable researchers to differentiate the impact of peptide modifications on receptor-mediated signaling, advancing the understanding of G protein-coupled receptor (GPCR) biology and downstream effector mechanisms.
Peptide stability and degradation studies: The succinimide-modified peptide serves as a model substrate for investigating proteolytic stability and degradation pathways in biological systems. By comparing the metabolic fate of teriparatide succinimide with that of unmodified analogs, scientists can assess the influence of specific chemical modifications on peptide half-life, susceptibility to enzymatic cleavage, and overall bioavailability in experimental settings. These insights are crucial for optimizing peptide therapeutics and understanding the determinants of peptide persistence in physiological environments.
Peptide synthesis optimization: In the context of synthetic peptide chemistry, teriparatide succinimide is utilized to evaluate and refine solid-phase synthesis strategies, particularly those involving side-chain modifications or cyclization steps. Its well-defined structure makes it an ideal test case for assessing the efficiency of coupling reagents, deprotection protocols, and purification techniques. These studies contribute to the advancement of synthetic methodologies for complex peptides and analog development.
Analytical method development: The compound is valuable in the development and validation of analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and capillary electrophoresis. Researchers use it as a reference standard or model analyte to calibrate detection systems, optimize separation parameters, and establish robust quantification protocols for peptide-based samples. These analytical capabilities are essential for ensuring reproducibility, sensitivity, and accuracy in biochemical and pharmaceutical research involving peptide compounds.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.